Cognition Therapeutics logo

Cognition Therapeutics Share Price Today

(NASDAQ: CGTX)

Cognition Therapeutics share price is $0.43 & ₹37.44 as on 6 Mar 2025, 2.30 'hrs' IST

$0.43

0.01

(2.45%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cognition Therapeutics share price in Dollar and Rupees. Guide to invest in Cognition Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cognition Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Cognition Therapeutics share price movements

  • Today's Low: $0.38
    Today's High: $0.45

    Day's Volatility :14.8%

  • 52 Weeks Low: $0.34
    52 Weeks High: $2.95

    52 Weeks Volatility :88.47%

Cognition Therapeutics (CGTX) Returns

PeriodCognition Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
13.99%
3.7%
0.0%
6 Months
-29.17%
-2.8%
0.0%
1 Year
-78.87%
2.5%
0.0%
3 Years
-83.86%
12.9%
-11.6%

Cognition Therapeutics (CGTX) Key Statistics

in dollars & INR

Previous Close
$0.4207
Open
$0.41
Today's High
$0.446
Today's Low
$0.38
Market Capitalization
$17.9M
Today's Volume
$404.9K
52 Week High
$2.95
52 Week Low
$0.34
Revenue TTM
$0.0
EBITDA
$-58.3M
Earnings Per Share (EPS)
$-0.96
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-157.9%

How to invest in Cognition Therapeutics Stock (CGTX) from India?

It is very easy for Indian residents to invest directly in Cognition Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cognition Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cognition Therapeutics or CGTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cognition Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cognition Therapeutics shares which would translate to 2.025 fractional shares of Cognition Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cognition Therapeutics, in just a few clicks!

Returns in Cognition Therapeutics (CGTX) for Indian investors in Rupees

The Cognition Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cognition Therapeutics investment value today

Current value as on today

₹26,143

Returns

₹73,857

(-73.86%)

Returns from Cognition Therapeutics Stock

₹78,922 (-78.92%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Cognition Therapeutics (CGTX)

-53%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cognition Therapeutics Stock from India on INDmoney has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cognition Therapeutics

  • BIOS CAPITAL MANAGEMENT, LP

    14.44%

  • Vanguard Group Inc

    2.98%

  • Sigma Planning Corp

    1.48%

  • Voss Capital LLC

    1.20%

  • Alyeska Investment Group, L.P.

    1.20%

  • Geode Capital Management, LLC

    0.85%

Analyst Recommendation on Cognition Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Cognition Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Cognition Therapeutics Stock (CGTX)

What analysts predicted

Upside of 1388.37%

Target:

$6.40

Current:

$0.43

Insights on Cognition Therapeutics Stock (Ticker Symbol: CGTX)

  • Price Movement

    In the last 1 month, CGTX stock has moved down by -32.6%
  • CGTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 145.4%
  • CGTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 134.4%

Cognition Therapeutics Technicals Summary

Sell

Neutral

Buy

Cognition Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Cognition Therapeutics (CGTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cognition Therapeutics, Inc. logo
-31.37%
-29.17%
-78.87%
-83.86%
-96.62%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cognition Therapeutics, Inc. logo
NA
NA
NA
-0.78
-1.58
-1.1
NA
0.36
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cognition Therapeutics, Inc. logo
Buy
$17.9M
-96.62%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Cognition Therapeutics

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.
Organization
Cognition Therapeutics
Employees
25
CEO
Ms. Lisa Ricciardi
Industry
Services

Management People of Cognition Therapeutics

NameTitle
Ms. Lisa Ricciardi
CEO, President & Director
Mr. John Brendan Doyle
Chief Financial Officer
Dr. Anthony O. Caggiano M.D., Ph.D.
Chief Medical Officer and Head of R&D
Dr. Steven A. Weissman Ph.D.
VP & Head of CMC
Ms. Anita Cornet
Head of Quality
Mr. Bobby Horn
Corporate Controller

Important FAQs about investing in CGTX Stock from India :

What is Cognition Therapeutics share price today?

Cognition Therapeutics share price today stands at $0.43, Open: $0.41 ; Previous Close: $0.42 ; High: $0.45 ; Low: $0.38 ; 52 Week High: $2.95 ; 52 Week Low: $0.34.

The stock opens at $0.41, after a previous close of $0.42. The stock reached a daily high of $0.45 and a low of $0.38, with a 52-week high of $2.95 and a 52-week low of $0.34.

Can Indians buy Cognition Therapeutics shares?

Yes, Indians can invest in the Cognition Therapeutics (CGTX) from India.

With INDmoney, you can buy Cognition Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cognition Therapeutics at zero transaction cost.

How can I buy Cognition Therapeutics shares from India?

It is very easy to buy Cognition Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cognition Therapeutics (CGTX) be purchased?

Yes, you can buy fractional shares of Cognition Therapeutics with INDmoney app.

What are the documents required to start investing in Cognition Therapeutics stocks?

To start investing in Cognition Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cognition Therapeutics Stock (CGTX)?

Today’s highest price of Cognition Therapeutics (CGTX) is $0.45.

Today’s lowest price of Cognition Therapeutics (CGTX) is $0.38.

What is today's market capitalisation of Cognition Therapeutics?

Today's market capitalisation of Cognition Therapeutics CGTX is 17.9M

What is the 52 Week High and Low Range of Cognition Therapeutics Stock (CGTX)?

  • 52 Week High

    $2.95

  • 52 Week Low

    $0.34

What are the historical returns of Cognition Therapeutics (CGTX)?

  • 1 Month Returns

    -31.37%

  • 3 Months Returns

    -29.17%

  • 1 Year Returns

    -78.87%

  • 5 Years Returns

    -96.62%

Who is the Chief Executive Officer (CEO) of Cognition Therapeutics ?

Ms. Lisa Ricciardi is the current Chief Executive Officer (CEO) of Cognition Therapeutics.